REPROCELL is a GLP-accredited CRO with labs in Glasgow and Durham, UK. Focussing on contract research using human fresh tissues, 3D models and stem cells, REPROCELL provides its clients with predictive data on the efficacy, safety and ADME profiles of new drug therapies. By using functional human tissues, REPROCELL provides clinically-relevant predictions of drug responses, which de-risks development and adds commercial value through early proof of concept.
REPROCELL are a member of our CRO Network, part of our Virtual R&D offering. You can find out more about them on their website.
